Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease
NCT: NCT07694921 · ENROLLING_BY_INVITATION
Brief Summary
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized primarily by cognitive impairment as its main clinical symptom, often accompanied by emotional disturbances such as depression and anxiety, imposing a significant disease burden. Temporal Interference Stimulation (TIS) is an emerging non-invasive electrical stimulation technique that precisely targets deep structures within the hippocampus through interference of multiple electric fields. This study will administer a two-week TIS treatment to patients with AD co-occurring depression, targeting the hippocampus, and compare changes in patients' cognitive function, scores on depression and anxiety scales, and functional magnetic resonance imaging (fMRI) data before and after treatment. An emotional word recall task will be administered during fMRI scans. The aim of this study is to investigate the efficacy, safety, and neural mechanisms of TIS-mediated modulation of hippocampal circuits in improving cognitive and emotional functioning in patients with AD and comorbid depression.
Frequently Asked Questions
What is Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease?
Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease is a clinical trial registered under NCT07694921. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07694921?
The current status of NCT07694921 (Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease) is: ENROLLING_BY_INVITATION.
When did Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease start?
Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease started on 2026-06-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.